CSL and Covax19, page-3

What a load of faeces! COVAX-19 just entered phase 3 trials in August this year. Prof. Petrovsky seems to be a bitter child who can’t see past the tip of his nose.

What probably happened is that they asked for the same deal Astra-Zeneca had, production without rights. CSL would not use resources (and their name) to produce an untested vaccine when they can be using their capacity to:
a. Create more needed (proven) vaccines.
b. Create plasma based products that generate their revenue.

CSL has joined in partnership with UQ previously for Novavax. If the same arrangement was sought by Vaxine, I do not see why CSL would reject it for a chance to gain profit with comparatively small cost (as they have the facilities).

Likely what Prof. Petrovsky is connivingly excluding from the interview is that they were perhaps trying to hardball a giant like CSL by either retaining most (or all) of the rights to the vaccine, or an un-enticing share of the profits should they work. No pharmaceutical giant is going to agree to produce vaccines for study without a significant return for risk should it be successful. That is the business of pharmaceutical companies.

Prof. Petrovsky clearly has an agenda and a vendetta. CSL should be suing his ass for misrepresentation and defamation.